Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties - Report - MDSpire

Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties

  • By

  • Carlota García-Escribano

  • Maria Gallardo-Jiménez

  • Ana García-Cadarso

  • Paloma Fernández Martínez

  • Ricardo Arroyo-Solera

  • Luis Senador Zaldívar-Martínez

  • Kelin Lin

  • Jeffrey Aubé

  • Patricia Barral

  • Tomás Chivato

  • Domingo Barber

  • Maria M. Escribese

  • Elena Izquierdo

  • Juan Carlos López-Rodríguez

  • June 26, 2026

  • 0 min

Share

Clinical Report: Collaborative Effects of IL-33 and IL-12 on MAIT Cells

Overview

This study investigates the effects of alarmins IL-33 and IL-12 on MAIT cell activation, revealing that IL-33 combined with IL-12p70 induces a strong IFNγ secretion profile.

Background

Mucosal-Associated Invariant T (MAIT) cells are critical in early immune responses, particularly against infections. Their activation is influenced by various cytokines, yet the role of alarmins in modulating MAIT cell function remains underexplored.

Data Highlights

No numerical data or trial data was provided in the article.

Key Findings

  • IL-33, in combination with IL-12p70, significantly enhances IFNγ secretion from MAIT cells.
  • The response of MAIT cells to IL-33 and IL-12p70 is dependent on p38 MAPK signaling and glycolytic metabolism.
  • Activated MAIT cells secrete a range of immune mediators, including TNF, VEGF, OSM, CXCL11, and CCL3.
  • Conditioned media from MAIT cells can polarize CD14+ monocytes towards a proinflammatory M1-like phenotype.
  • MAIT cells exhibit potential for broader immunomodulatory functions beyond microbial infections.

Clinical Implications

The findings suggest that targeting IL-33 and IL-12 pathways may enhance MAIT cell responses in inflammatory conditions. Understanding MAIT cell activation could inform therapeutic strategies in diseases characterized by dysregulated inflammation.

Conclusion

This study highlights the significant role of IL-33 and IL-12 in modulating MAIT cell function.

Related Resources & Content

  1. Journal of Gastroenterology, 2017 -- Significance of the IL-22 Pathway in Inflammatory Bowel Disease
  2. The Journal of Infectious Diseases, 2023 -- c-Myc Modulates the Antimycobacterial Activity of Macrophages During Mycobacterium tuberculosis Infection
  3. Frontiers in Immunology, 2026 -- Treg-Derived IFN-γ Supports the Differentiation of Th1-Treg in tumor immunity and autoimmunity
  4. The ASCO Post, 2014 -- IL-17A Promotes and GM-CSF Suppresses Circulating Tumor Cells and Metastasis in Colorectal Cancer
  5. Frontiers | Control of MAIT cell functions by cytokines in health and disease
  6. Global Strategy for Asthma Management and Prevention, 2025
  7. FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma
  8. Frontiers | Control of MAIT cell functions by cytokines in health and disease
  9. Global Strategy for Asthma Management and Prevention
  10. FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma - PMC

Original Source(s)

Related Content